Indian company acquires rights to copy generic cancer drug
Indian pharmaceutical company, Natco Pharma, has been authorized to manufacture an expensive anti-cancer drug originally developed by Bayer Corporation. This move, although undermining the Bayer’s patent, is expected More...
FDA Grants clearance to a disinfecting port protector
Carlsbad, California (USA) – Ivera Medical Corporation today announced that it has received a new FDA 510(k) clearance for its Curos disinfecting port protector. The Curos passive disinfection cap first More...
Wockhardt gets US FDA’s consent for Fluticasone nasal spray
US Food and Drug Administration recently gave its final approval to drug firm Wockhardt for marketing of generic Fluticasone nasal spray, in the American market. Fluticasone nasal spray is generally used for treating More...
Ranbaxy gets Green signal for Lipitor from US FDA
US Food and Drug Administration grants Ranbaxy Laboratories a final approval for Atrovastatin Calcium -Abbreviated New Drug Application (ANDA) in multiple strengths of 10 mg, 20 mg, 40 mg and 80 mg. Pfizer first More...
Declining funds jeopardizing UN victory in battle against AIDS?
UN walks towards victory with diminishing HIV infection and climbing treatment as per last decade’s AIDS response scenario. However, sadly, declining funds pose some risks to this unprecedented progress towards More...
IBM’s new software launch: turns over a new leaf in the healthcare segment
Healthcare providers and payers can now analyze world’s data very efficiently, to provide improved patient care at reduced costs, with latest software introduced by IBM on October 25, 2011. Interestingly, this More...